Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial

IMPORTANCE: Glucagon-like peptide-1 (GLP-1) receptor agonists are effective therapies for the treatment of type 2 diabetes and are all currently available as an injection. OBJECTIVES: To compare the effects of oral semaglutide with placebo (primary) and open-label subcutaneous semaglutide (secondary...

詳細記述

保存先:
書誌詳細
出版年:JAMA
主要な著者: Davies, Melanie, Pieber, Thomas R., Hartoft-Nielsen, Marie-Louise, Hansen, Oluf K. H., Jabbour, Serge, Rosenstock, Julio
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2017
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817971/
https://ncbi.nlm.nih.gov/pubmed/29049653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2017.14752
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料